Skip to content

Pentoxifyllin ointment in treatment of bedsore

Comparing efficacy of pentoxifyllin ointment and placebo in treatment of bedsore in patients hospitalized in intensive care unit

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201402233449N16
Enrollment
100
Registered
2014-03-13
Start date
2014-02-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bedsore. The ulcer appears as a defined area of persistent redness (erythema) in lightly pigmented skin, whereas in darker skin tones, the ulcer may appear with persistent red, blue or purple hues, without skin loss

Interventions

Intervention 1: Pentoxifyllin 5% ointment (formulated in the faculty of pharmacy affiliated to Tehran University of Medical Sciences) twice daily topically cover all sores area for 14 days. Interventi
Treatment - Drugs
Placebo
Pentoxifyllin 5% ointment (formulated in the faculty of pharmacy affiliated to Tehran University of Medical Sciences) twice daily topically cover all sores area for 14 days

Sponsors

Vice Chancellor for Research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Critically ill patients with grade 1 or 2 of bedsore, who will be hospitalized in Intensive Care Unit (ICU) for at-least 14 days and without history of pentoxifyllin hypersensitivity. Exclusion Criteria: Patients with severe bedsore requiring antibiotic therapy and worsening of bedsore during treatment course will be excluded from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Grade of bedsore. Timepoint: At ICU admission and then day 14 of hospitalization. Method of measurement: 2-digit Stirling scale.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026